SIM
HSTO

SSI Investment Management’s Histogen Inc. Common Stock HSTO Stock Holding History

SSI Investment Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-197
Closed -$276K – 362
2014
Q4 		$276K Buy
+197
New +$285K 0.03% 296

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

SSI Investment Management's HSTO Position: Q1 2015 in Review

SSI Investment Management sold out of Histogen Inc. Common Stock (HSTO) in Q1 2015, closing a stake of 197 shares — an estimated $276K sold.

SSI Investment Management first reported a position in HSTO in Q4 2014 and held it in 1 quarter. The position peaked at $276K in Q4 2014. 32 funds tracked by Wall St. Rank hold HSTO as of Q1 2015.

  • SSI Investment Management reported no remaining Histogen Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • SSI Investment Management sold 197 Histogen Inc. Common Stock shares in Q1 2015, an estimated $276K.
  • SSI Investment Management first reported a position in Histogen Inc. Common Stock in Q4 2014 and held it in 1 quarter.
  • SSI Investment Management's Histogen Inc. Common Stock position peaked at $276K in Q4 2014.
  • 32 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2015.

Based on SSI Investment Management's 13F filing for Q1 2015, filed 12 May 2015.